Invention Grant
- Patent Title: Composition of 5-nitrobenzoate derivatives as anti-metastatic agent that inhibits tumor cell-induced platelet aggregation
-
Application No.: US14287735Application Date: 2014-05-27
-
Publication No.: US09604910B2Publication Date: 2017-03-28
- Inventor: Ching-Ping Tseng , Pei-Wen Hsieh , Yao-Wen Chang
- Applicant: CHANG GUNG UNIVERSITY
- Applicant Address: TW Tao-Yuan
- Assignee: CHANG GUNG UNIVERSITY
- Current Assignee: CHANG GUNG UNIVERSITY
- Current Assignee Address: TW Tao-Yuan
- Agency: Porzio, Bromberg & Newman, P.C.
- Main IPC: C07C231/08
- IPC: C07C231/08 ; C07C233/65 ; C07C235/60

Abstract:
Disclosed are 5-nitrobenzoate derivatives of Formula I, and the preparation method therefor, wherein R is referred to hydrogen (H), unsubstituted, mono-substituted, di-substituted or tri-substituted benzoyl moiety. 5-Nitrobenzoare derivatives of Formula I do not affect the platelet aggregation, possesses the inhibitory activity related to the tumor cell-induced platelet aggregation (TCIPA), and further specifically inhibits podoplanin-induced platelet aggregation. Therefore, 5-nitrobenzoates of the invention are applicable in its therapeutic use as the novel therapeutic agent in preventing tumor metastasis.
Public/Granted literature
Information query